Emcure Pharmaceutical is a multinational pharmacy giant that transitioned from a private entity to a publicly listed company in 2024. The company’s products focus on woman healthcare, cardiology and HIV antiviral. Over the years, the company has undergone various changes but has continued to hold its reputation in pharmaceutical industry.
Emcure Pharmaceutical – Overview
| Particulars | Details |
| Company Name | Emcure Pharmaceutical |
| Industry | Pharmaceutical Manufacturing and Research Company |
| Type | Public Lisited Company |
| Founded | 1981 |
| Founder | Satish Mehta |
| Headquarters | Hinjawadi, Pune, India |
| Managing Director & CEO | Satish Mehta (Founder) |
| Chairman | Berjis Minoo Desai |
| Distribution Network | Pan India, Exports to 70 plus countries |
| Reach | Global Presence with strong hold in India, Europe and Canada |
| Service Portfolio | Gynaecology, Cardiology, HIV/AIDS |
| Official Website | www.emcure.com |
Net Worth and Market Cap
Emcure Pharmaceutical has established a strong financial footing through consistent growth. The estimated net worth of the company exceeds ₹3,024.36 Cr due to its global presence. As of early 2026, the market capitalization of Emcure Pharmaceutical is around ₹27,174 Cr – ₹29,019 Cr based on the market conditions and cycles in the sector.
Corporate Leadership
Emcure Pharmaceutical was founded in 1981 by Satish Mehta, a young graduate from IIM-A. Satish Mehta was first generation entrepreneur who started the firm with a small bank loan. Emcure was started with a vision to manufacture high quality generic drugs in India. The company maintains a high-profile leadership through Satish and his team of the board that combines decades of experience with modern business strategy.
Overview of Services
Pune-based global pharmaceutical company Emcure Pharmaceutical specialises in the development, manufacturing, and marketing of a wide range of products. It specialises in oral solids (tablets and capsules), injections and biotherapeutics. It also develops and manufactures complex Active Pharmaceutical Ingredients, including chiral and cytotoxic molecules. Apart from this, through its subsidy Gennova, the company manufactures biologics and biosimilar products like tenecteplase and pegylated-asparaginase. There has been news that the company has recently entered the dermatology space.
Scale of Operations
Emcure Pharmaceutical has a strong global footprint and exports to 70-plus countries. It operates 13 modern manufacturing plants across different locations in India. These plants are approved by global regulatory bodies like the USFDA, UK-MHRA and Health Canada. Emcure Pharmaceutical acts as a high-quality manufacturing partner for global pharmaceutical majors. It operates through a vertically integrated supply chain, ensuring quality from API to finished dosage forms.
